Zymeworks Inc logo

Zymeworks Inc

ZYME
Healthcare|Biotechnology|USA
$25.88
-1.19 (-4.40%)
Tangible Book
$2.04

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 314.54, 220.72, 240.12, 342.19, 469.59 ], "ebit_estimate": [ 98.44, 87.99, 48.5, 103.76, 122.7 ], "ebitda_estimate": [ 75.47, 112.06, 102.71, null, null ], "net_income_estimate": [ 89.23, 84.2, 47.71, 83.56, 94.33 ], "per_share_eps_estimate": [ 1.54, 0.69, 0.45, 1.14, 1.12 ], "eps_nri_estimate": [ 1.11, 0.48, 0.54, 1.01, 1.12 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ 124.87, 93.63, 49.92, 89.65, 100.93 ], "operating_cash_flow_per_share_estimate": [ 1.61, -0.7, null, null, null ], "roa_estimate": [ 15.9, -11.9, null, null, null ], "roe_estimate": [ 26.66, -20.4, 16.55, null, null ], "gross_margin_estimate": [ 98.9, 91.5, 100, 100, 100 ], "operating_cash_flow_estimate": [ 120.26, -52.29, null, null, null ], "pettm_estimate": [ 16.85, 37.51, 57.64, 22.8, 23.07 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ 20.82, 189.06, 131.66, 79.14, 80.05, 102.56, 68.1, null ], "ebit_estimate": [ -31.98, 130.49, 65.48, -16.36, 62.09, 104.74, -7.53, null ], "ebitda_estimate": [ -44.37, 192.25, -25.93, null, null, null, null, null ], "net_income_estimate": [ -30.24, 124.51, 59, -21.86, 40.56, 71.55, -14.01, null ], "per_share_eps_estimate": [ -0.4, 1.51, 0.96, -0.31, 0.58, 1.02, -0.2, -0.28 ], "eps_nri_estimate": [ -0.44, 1.86, 0.56, 0.3, 0.23, 0.45, -0.3, -0.28 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -30.73, 130.44, 66.06, -21.86, 55.56, 98.01, -14.01, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ -105.87, 340.04, -40.26, null, null, null, null, null ], "gross_margin_estimate": [ 100, 100, 100, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 14.65, 9.44, 11.48, 23.74, 23.07, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-07-07 13:08:05
2026-06-30 15:01:37
2026-06-29 18:00:12
2026-06-29 10:56:52
2026-06-18 13:00:05
2026-06-14 23:25:37